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Abstract 
Certain studies have suggested that the tumor necrosis factor‑α (TNF‑α) −857 C/T polymorphism is associated with 
risk of ankylosing spondylitis. However, the conclusions remain controversial. Therefore, we performed a meta‑analysis 
to provide a more precise conclusion. Such databases as PubMed, Embase, CBM, CNKI, and Wanfang Data were 
searched to identify relevant studies up to August 26, 2015. Odds ratios (ORs) and 95% confidence intervals (CIs) were 
used to estimate the association between TNF‑α −857 C/T polymorphism and ankylosing spondylitis susceptibility. 
A total of 10 studies were included in the meta‑analysis. Overall, an elevated risk between TNF‑α −857 C/T polymor‑
phism and ankylosing spondylitis was observed in three genetic model (T vs. C: OR 1.86, 95% CI 1.19–2.92; CT vs. CC: 
OR 2.51, 95% CI 1.49–4.23; TT + CT vs. CC: OR 2.46, 95% CI 1.40–4.30), except in homozygote model (TT vs. CC: OR 
2.41, 95% CI 0.96–6.06) and recessive model (TT vs. CT + CC: OR 1.54, 95% CI 0.71–3.35). Sensitivity analysis showed 
the overall results were robust. Subgroup analyses according to Hardy–Weinberg equilibrium and ethnicity showed 
that the increased risk of ankylosing spondylitis were predominant in Asian population. This meta‑analysis indicated 
that TNF‑α −857 C/T polymorphism might increase the susceptibility of ankylosing spondylitis, especially in Asians. 
Further studies were needed to verify the conclusion.
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Background
 Ankylosing spondylitis is a chronic inflammatory rheu-
matic disease that causes pain in the neck, back and 
even hips and heels (Braun and Sieper 2007). The dis-
ease lowers the quality of life of patients and presents 
a huge burden on society. The etiology and pathogen-
esis of ankylosing spondylitis remain obscure. Ankylos-
ing spondylitis is a multifactorial disease that involves 
both genetic and environmental factors. Human leuko-
cyte antigen-B27 (HLA-B27) was identified as the first 
genetic factor of ankylosing spondylitis (Brewerton et al. 
1973; Schlosstein et al. 1973). However, HLA-B27 is not 
the sole pathological factor in all patients with ankylos-
ing spondylitis. Increasing evidence suggested that non-
HLA-B27 genes are also contribute to the development 
of ankylosing spondylitis (Rubin et al. 1994; Van Der Lin-
den et al. 1984).
Numerous studies have investigated the association 
between tumor necrosis factor-α (TNF-α) −857 C/T 
polymorphism and the risk of developing ankylosing 
spondylitis. Results of clinical and epidemiological stud-
ies indicate that the relationship between variations and 
risk of developing ankylosing spondylitis is complicated. 
In recent years, four meta-analyses (Lee and Song 2009; 
Li et al. 2010; Ma et al. 2013; Wang et al. 2013) evaluated 
the association between TNF-α gene polymorphism and 
risk of developing ankylosing spondylitis. However, only 
one meta-analysis (Ma et al. 2013) analysed the associa-
tion between −857 C/T polymorphism and the risk of 
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developing ankylosing spondylitis with two studies of 
small sample size. Currently, more studies addressing 
the association between −857 C/T polymorphism and 
the risk of ankylosing spondylitis have been published. 
Therefore, we performed a meta-analysis to provide a 
more precise conclusion on the association between 




To identify eligible studies, such as PubMed, Embase, 
CBM, CNKI and Wanfang Data were searched until 
August 26, 2015, with the following items: [(“tumor 
necrosis factor-α” OR TNF-α) AND “ankylosing spondy-
litis” AND (polymorphism OR mutation OR variation)]. 
Bibliographies of the included studies were manually 
searched for additional papers.
Study selection criteria
A study was included if it met the following criteria: (1) 
case–control study or cohort study design; (2) addressed 
the association between TNF-α −857C/T polymorphism 
and susceptibility to ankylosing spondylitis; (3) case 
group was patients with ankylosing spondylitis, and con-
trol group was patients without ankylosing spondylitis; 
and (4) genotype distribution was provided. Additionally, 
we excluded abstracts, no sufficient data and duplicated 
publication.
Data extraction
Two researchers independently extracted the following 
information: author, publication year, sample size, geno-
type distribution, genotyping method and Hardy–Wein-
berg equilibrium (HWE) for controls. Any disagreements 
were resolved through consensus.
Statistical analysis
The χ2 test was used to examine the HWE for controls. 
The odds ratios (ORs) and 95% confidence intervals (CIs) 
were calculated to measure the association between 
TNF-α −857 C/T polymorphism and susceptibility to 
ankylosing spondylitis susceptibility using the follow-
ing genetic models: allelic contrast (T vs. C), homozy-
gote contrast (TT vs. CC), heterozygote contrast (CT 
vs. CC), dominant model (TT + CT vs. CC), and reces-
sive model (TT vs. CT +  CC) (Song et  al. 2015; Weng 
et  al. 2015). Heterogeneity between studies was tested 
using the Q-test and I2 statistic (Higgins and Thompson 
2002). The random-effects model was used to aggregate 
the results of the included studies if no heterogeneity 
was existed (P < 0.1). Otherwise, the fixed-effects model 
was used. Subgroup analysis was performed according to 
ethnicity and HWE in controls. Sensitivity analysis was 
performed by removing each study at a time. Publication 
bias was assessed using Begg’s funnel plot and Egger’s lin-
ear regression test (Egger et al. 1997). The level of signifi-
cance was set at 0.05, except for the heterogeneity test.
Results
Study characteristics
Of the 253 publications retrieved initially, 10 studies, 
which involved 987 ankylosing spondylitis patients and 
1041 controls (Cai et  al. 2009; Chatzikyriakidou et  al. 
2009; Chen et al. 2004; Chung et al. 2011; Ji et al. 2013; 
Li et  al. 2007; Lin 2007a, b; Mei et  al. 2009; Tong et  al. 
2012; Yang et  al. 2007), were ultimately identified. Fig-
ure  1 shows the flowchart of the study selection pro-
cess. Table 1 presents the characteristics of the included 
studies.
Meta‑analysis
The results of the present meta-analysis are shown in 
Table 2. Overall, an elevated risk was observed between 
TNF-α −857C/T polymorphism and susceptibility to 
ankylosing spondylitis through four genetic models (T 
vs. C: OR 1.86, 95% CI 1.19–2.92, Fig. 2; CT vs. CC: OR 
2.51, 95% CI 1.49–4.23; TT + CT vs. CC: OR 2.46, 95% 
CI 1.40–4.30) with a random-effects model (Table 2). No 
significant association was observed only in the homozy-
gote model (TT vs. CC: OR 2.41, 95% CI 0.96–6.06) 
and recessive model (TT vs. CT + CC: OR 1.54, 95% CI 
0.71–3.35). Subgroup analyses based on HWE in controls 
and ethnicity showed similar results to the overall results 
(Table  2). Sensitivity analysis, which was conducted by 
removing each one study that included in the analysis, 
did not significantly change the results (Fig. 3).
Heterogeneity and publication bias
Moderate to high between-study heterogeneity was 
detected in the five genetic models. Begg’s funnel plot 
was symmetric for all five genetic models. Figure 4 shows 
the shapes of the funnel plots of the T vs. C genetic 
model. The result was further supported by Egger’s tests 
(P = 0.65 for T vs. C genetic model).
Discussion
The TNF cluster genes are implicated in the susceptibil-
ity to certain immunopathological diseases such as anky-
losing spondylitis. The TNF-α gene is one of the class III 
regions and is located in the class I and class II regions. 
Many studies indicated that the TNF-α gene plays a vital 
role in the pathogenesis of ankylosing spondylitis because 
of the location and relevant biological properties of the 
gene site. Numerous studies have evaluated the associa-
tion between TNF-α polymorphisms and susceptibility to 
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Fig. 1 Flow chart of the study selection
Table 1 Characteristics of individual studies included in the meta-analysis
PB population-based, HB hospital-based, HWE Hardy–Weinberg equilibrium
References Country (ethnicity) Sample size Genotyping method Case HWE Control
Case Control CC CT TT CC CT TT
Chen et al. (2004) China (Asian) 107 116 RTDF‑PRCR 32 61 14 Yes 88 27 1
Lin (2007a, b) China (Asian) 136 127 SSP‑PCR 87 48 1 Yes 90 35 2
Li et al. (2007) China (Asian) 164 121 AS‑PCR 58 130 6 Yes 55 58 8
Yang et al. (2007) China (Asian) 54 42 Gene chip 29 23 2 Yes 34 8 0
Chatzikyriakidou et al. (2009) Greece (Caucasian) 49 68 PCR‑RFLP 33 3 13 No 40 5 23
Cai et al. (2009) China (Asian) 112 96 SSP‑PCR 34 69 9 Yes 72 22 2
Mei et al. (2009) China (Asian) 83 200 PCR 36 42 5 Yes 144 49 7
Chung et al. (2011) Korea (Asian) 119 135 PCR‑RFLP 95 24 0 Yes 90 43 2
Tong et al. (2012) China (Asian) 106 106 MALDI‑TOF 39 47 20 Yes 72 29 5
Ji et al. (2013) China (Asian) 57 30 PCR‑RFLP 10 44 3 Yes 14 14 2
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ankylosing spondylitis. Most of these studies focused on 
the −238 G/A and −308 G/A polymorphisms. In recent 
years, four meta-analyses (Lee and Song 2009; Li et  al. 
2010; Ma et  al. 2013; Wang et  al. 2013) were published 
for these two polymorphisms and their the correlation 
with susceptibility to ankylosing spondylitis. Only one 
meta-analysis (Ma et  al. 2013) investigated the associa-
tion between the TNF-α gene −857 C/T polymorphism 
and risk of developing ankylosing spondylitis. However, 
the previous meta-analysis only included two studies that 
focused on the −857 C/T variation. This meta-analysis 
showed a significant association in the CT vs. CC genetic 
model with a reduced risk of developing ankylosing 
spondylitis. Numerous studies examining the association 
between the TNF-α −857 C/T polymorphism and risk 
of ankylosing spondylitis have been published in China 
recently, but results remain controversial. Meta-analysis 
is a well-known as a statistical method to aggregate pre-
vious studies and to increase statistical power, providing 
more precise results than individual studies (Jung et  al. 
2015; Niu et al. 2015; Song et al. 2015; Weng et al. 2015). 
Hence, meta-analyses are a powerful method for summa-
rizing evidence from different studies.
 In the present meta-analysis, we included 10 studies 
(Cai et al. 2009; Chatzikyriakidou et al. 2009; Chen et al. 
2004; Chung et al. 2011; Ji et al. 2013; Li et al. 2007; Lin 
2007a, b; Mei et  al. 2009; Tong et  al. 2012; Yang et  al. 
2007) that addressed the association between TNF-α 
−857 C/T polymorphism and risk of developing ankylos-
ing spondylitis. The results of this meta-analysis indicated 
that T allele carriers presented a 1.76-fold higher risk 
of developing ankylosing spondylitis than C allele carri-
ers, CT genotype carriers presented a 2.30-fold higher 
risk than CC genotype and TT + CT genotype carriers 
presented a 2.26-fold higher risk than CC genotype. No 
significant association was observed in TT genotype car-
riers compared with CT  +  CC and CC genotypes car-
riers. Our meta-analysis was differed from a previous 
meta-analysis in that the previous work (Ma et al. 2013) 
included two studies (one for Greece and one for Korea 
populations), whereas the present meta-analysis focused 
on the overall population. Moreover, we performed sub-
group analysis according to ethnicity.
Some limitations should be taken into consideration 
in the present meta-analysis. First, the between-study 
heterogeneity was moderate to high in the five genetic 
Table 2 The results of meta-analysis with five genetic models
HWE Hardy–Weinberg equilibrium, R random-effect model, OR odds ratio, CI confidence interval
Genetic model Subgroups No. of studies Heterogeneity Test of association
Model P value I2 (%) OR 95% CI P value
T versus C Overall 10 R <0.001 88.0 1.86 1.19–2.92 0.007
HWE (yes) 9 R <0.001 87.1 2.07 1.32–3.26 0.002
Asian 9 R <0.001 87.1 2.07 1.32–3.26 0.002
Caucasian 1 R – – 0.07 0.40–1.22 0.21
TT versus CC Overall 10 R <0.001 71.9 2.41 0.96–6.06 0.06
HWE (yes) 9 R 0.004 64.7 2.97 1.14–7.75 0.03
Asian 9 R 0.004 64.7 2.97 1.14–7.75 0.03
Caucasian 1 R – – 0.69 0.30–1.56 0.37
CT versus CC Overall 10 R <0.001 84.0 2.51 1.49–4.23 0.001
HWE (yes) 9 R <0.001 85.1 2.72 1.59–4.66 <0.001
Asian 9 R <0.001 85.1 2.72 1.59–4.66 <0.001
Caucasian 1 R – – 0.73 0.16–3.2 0.68
TT + CT versus CC Overall 10 R <0.001 87.9 2.46 1.40–4.30 0.002
HWE (yes) 9 R <0.001 87.5 2.80 1.59–4.96 <0.001
Asian 9 R <0.001 87.5 2.80 1.59–4.96 <0.001
Caucasian 1 R – – 0.69 0.32–1.49 0.35
TT versus CC + CT Overall 10 R 0.005 62.1 1.54 0.71–3.35 0.28
HWE (yes) 9 R 0.011 59.8 1.77 0.74–4.25 0.20
Asian 9 R 0.011 59.8 1.77 0.74–4.25 0.20
Caucasian 1 R – – 0.71 0.31–1.59 0.40
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models. Heterogeneity might decrease the precision 
and reliability of the results. The heterogeneity might 
be derived from clinical heterogeneity such as genotyp-
ing method and diagnosis of disease. Second, the major 
criticism of this meta-analysis is the limited quantity 
of included studies. The TT genotype is a homozygous 
mutant at the −857 position in the TNF-α promoter. 
Given the small sample size, the rare frequency of the TT 
genotype might not have sufficient statistical power for 
detecting the true association between the variation and 
risk of developing ankylosing spondylitis. Third, HLA-
B27 has been identified as a risk factor for developing 
ankylosing spondylitis, and the gene–gene interactions 
could not be provided because of the insufficient data 
presented in the original studies. Hence, further origi-
nal studies should present the association between the 
polymorphisms and the risk of developing ankylosing 
spondylitis in HLA-B27 positive population. Although 
no evidence of publication bias was detected in the pre-
sent meta-analysis, it is inevitable (Weng et  al. 2015). 
Lastly, the major study population in this meta-analysis 
is Asians; hence, the conclusion of the meta-analysis is 
only suitable for Asian populations. Genomic mark-
ers may have remarkable value if the meaningful results 
are identified, and the technique is relatively simple and 
inexpensive. Even though the limitations constrained the 
precision and validity of the results, this meta-analysis 
still provided certain information about the effect of the 
prevention and/or treatment of ankylosing spondylitis 
on public health.
Conclusions
Our meta-analysis indicated that the TNF-α −857 C/T 
polymorphism might increase the risk of ankylosing 
spondylitis, especially in Asian populations. Further 
studies are necessary to validate the conclusion.
Fig. 2 Forest plots of the meta‑analysis for T versus C genetic model
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